Business Details
30 Years
experience
Emergency
services
Your Trusted Specialty Pharmaceutical Partner in North America
Methapharm is a specialty pharmaceutical company dedicated to developing, acquiring, licensing, and promoting healthcare products across North America. Founded in 1996 as a spin-off from an API group of companies, we have built a reputation for delivering high-quality specialty pharmaceuticals to address unmet medical needs. Our mission centers on enhancing patient care by making critical products accessible to practitioners and patients. Over the years, we have expanded our capabilities to include partnerships with global pharmaceutical companies, enabling us to distribute prescription drugs in all U.S. states and Canada. Our comprehensive approach integrates research, product development, and strategic collaborations to ensure a steady supply of innovative solutions.With distribution facilities in North America and a growing international network, we serve as a trusted partner for specialty products in therapeutic areas such as respiratory, imaging, oncology, and neonatology. Our leadership team brings decades of industry expertise, driving our commitment to quality, compliance, and patient-centric care. We prioritize transparency, ethical practices, and continuous improvement to maintain our position as a leader in the pharmaceutical sector. Our focus on unmet medical needs and quality of life improvements underscores every aspect of our operations.
Services
Respiratory Products
Neonatology Products
Pharmacy Products
Hospital Products
Product Pipeline
Business Development
Details
- Year established: 1996
Highlights and features
- We have over 30 years of experience in the pharmaceutical industry.
- Our partnerships with global companies ensure a comprehensive product line.
- Licensed to distribute in all U.S. states and Canada.
- Focus on unmet medical needs in respiratory, oncology, and neonatology.
- Experienced leadership team with expertise in pharmaceutical development.
Services
Respiratory Products
Methapharm develops and distributes respiratory diagnostic products and therapies. Our offerings address chronic conditions like asthma and COPD, improving patient outcomes through innovative solutions. Backed by global partnerships and decades of pharmaceutical expertise, we ensure reliable access to critical treatments.
Neonatology Products
Our neonatology portfolio supports specialized care for newborns, focusing on premature and critically ill infants. We provide essential medications and diagnostics through strategic partnerships, ensuring safety and efficacy. With industry-leading R&D and distribution capabilities, we address unique neonatal healthcare challenges.
Product Pipeline
Methapharm's pipeline includes projects in respiratory, allergy, and CNS therapeutic areas. We advance candidates through in-licensing, acquisition, and R&D collaborations. Our 2024-2025 launches reflect a commitment to innovation and addressing unmet clinical needs in specialty medicine.
Business Development
We facilitate pharmaceutical partnerships for product acquisition, licensing, and market expansion. Our team leverages global networks to identify opportunities in specialty drugs and diagnostics. With expertise in regulatory compliance and commercialization, we create value for partners and patients alike.
Hospital Products
Methapharm supplies critical hospital products, including diagnostic tools and specialty medications. Our offerings support diverse clinical settings through reliable distribution networks. By partnering with leading manufacturers, we ensure healthcare providers have access to high-quality, life-saving resources.
People
Craig Baxter
CEO / President
With over 30 years in pharmaceuticals, Craig Baxter leads Methapharm's global strategy. He has held executive roles at Apotex and Cangene Corporation, driving growth in manufacturing and sales. His expertise spans international markets and healthcare innovation.
Chris Calenti
Executive Vice President / CLO
Chris Calenti oversees business development and legal affairs. A licensed attorney with an MBA, he brings 20 years of experience in pharmaceutical licensing and partnerships. His focus is on expanding Methapharm's global commercial opportunities.
Sharron Brownlee
Vice President - North America, Specialty
Sharron Brownlee leads North American specialty sales with 20 years in pharmaceutical market access. She holds advanced degrees in marketing and international relations, driving strategic partnerships and market expansion for Methapharm's portfolio.
Matthew Baxter
Vice President, Respiratory
Matthew Baxter directs respiratory diagnostics, leveraging a decade of product development experience. With a chemical engineering background, he manages global commercialization efforts for Methapharm's respiratory portfolio, ensuring alignment with clinical and market needs.
John Zanin
Director of Operations
John Zanin oversees operations with 20+ years in pharmaceutical manufacturing and supply chain. His expertise in API production and quality systems ensures seamless delivery of specialty products across domestic and international markets.
Questions
What therapeutic areas does Methapharm focus on?
Methapharm focuses on respiratory, imaging, oncology, neonatology, and hospital products to address unmet medical needs.
Does Methapharm offer emergency services?
Yes, emergency SAP orders in Canada can be placed via CPDN at 1-877-859-6336 (24/7).
What regions does Methapharm serve?
Methapharm operates in North America (USA, Canada) and is expanding its international diagnostic product network.
How does Methapharm partner with other companies?
We collaborate through acquisition, licensing, and business development to distribute global pharmaceutical products in North America.
